Safety Recall: Saishunkan Seiyaku Medicated Beauty Serum and Medicated Cream – Japan CAA

Published by Reclia Safety Desk | June 29, 2026

🚨 Recall Alert

Product: Medicated Beauty Serum and Medicated Cream

Brand: Saishunkan Seiyaku

Hazards: Safety Risk

🇯🇵 Official Japan CAA Recall Notice
Case #00000035449 | View original notice ->

📋 Inscription Fact Summary

Product: Medicated Beauty Serum and Medicated Cream

Brand: Saishunkan Seiyaku

Case Number: #00000035449

Recall Information Record

Case Number: 00000035449
Product: Medicated Beauty Serum and Medicated Cream
Brand: Saishunkan Seiyaku
Hazards: Safety Risk
Source: Japan Consumer Affairs Agency (CAA)

WHAT HAPPENED

Saishunkan Pharmaceutical Co., Ltd. has issued a recall for its Domohorn Wrinkle Medicated Serum b and Medicated Cream c products. The recall was triggered by a procedural failure: the products were shipped before the mandatory release judgment procedures were completed, even though the test inspections themselves had passed. This administrative oversight raises concerns about compliance with Good Manufacturing Practice (GMP) standards.

While no safety issues have been identified in the actual product quality, the deviation from standard operating procedures undermines the traceability and accountability required for pharmaceutical products. Consumers who have purchased these items may be affected by the lack of proper release documentation, which is critical for ensuring product integrity and regulatory compliance.

If you have purchased the affected products, please take the following steps:

  • Check the product name: Domohorn Wrinkle Medicated Serum b or Medicated Cream c.
  • Contact Saishunkan Pharmaceutical’s customer service for return and refund instructions.
  • Do not continue using the product until you have confirmed the recall details with the company.
  • Visit the PMDA website or the Consumer Affairs Agency recall site for official updates.

AFFECTED BATCHES & TARGET SPECIFICS

– **Target Model / Type:** N/A
– **JAN Barcode:** N/A
– **Affected Serial / Lot Numbers:** N/A
– **Total Units Affected:** N/A

ADDITIONAL REGULATORY NOTES

The recall was initiated because the products were shipped without completing the required release judgment procedures, although the test inspections had passed. The recall start date is March 3, 2026. Reference information is provided by PMDA (Pharmaceuticals and Medical Devices Agency).

📅 Timeline: Synchronized Registry Ingestion Engine Active.

❓ Frequently Asked Questions

Q: Which Saishunkan Seiyaku products are affected by this safety list?

A: The recall covers specific batches of Medicated Beauty Serum and Medicated Cream. Refer to official dossier #00000035449 for verified metrics.

Q: What physical hazard does this present?

A: Identified hazard vectors include: Safety Risk.

Q: What actions should affected users take?

A: Stop using the unit immediately. Follow official safety guidelines: View original CAA notice.

Disclaimer: Information on this page is summarized from official Japan Consumer Affairs Agency (CAA) recall notices.

Consumers should refer to the original Japan CAA notice for complete details.

Leave a Comment